Intravitreal brolucizumab is superior to panretinal laser photocoagulation in preserving visual acuity for patients with proliferative diabetic retinopathy, clinical trial data show.

Changes in Choroidal Thickness Following Panretinal Photocoagulation: A Retrospective Study from Al Qassim, Saudi Arabia.

Please provide your email address to receive an email when new articles are posted on . The phase 3 BUTTERFLEYE trial compared aflibercept vs. laser photocoagulation in infants with retinopathy of ...

Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach. What are the ...

Why did a 38-year-old woman with neurofibromatosis type 1 (NF1) develop choroidal Yasunari nodules in both eyes? That's what Danish clinicians had to figure out when the patient presented for a ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

The phase 3 CONDOR trial found brolucizumab superior to panretinal laser photocoagulation for proliferative diabetic retinopathy, offering better vision outcomes and disease regression. The anti-VEGF ...

The goal of systemic management of risk factors (glucose, blood pressure and lipid control) is to prevent diabetic retinopathy (DR) incidence or progression to vision-threatening DR. The greatest ...

* Laser photocoagulation helps slow vision loss in people with wet age-related macular degeneration * The laser seals leaking// blood vessels beneath the macula to prevent further damage * While it ...